Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 224

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution

Open access
Caronna, Edoardo, Ballvé, Alejandro, Llauradó, Arnau, Gallardo, Victor José, Ariton, Diana María, Lallana, Sofia, López Maza, Samuel, Olivé Gadea, Marta, Quibus, Laura, Restrepo, Juan Luis, Rodrigo-Gisbert, Marc, Vilaseca, Andreu, Hernandez Gonzalez, Manuel, Martinez Gallo, Monica, Alpuente, Alicia, Torres-Ferrus, Marta, Pujol Borrell, Ricard, Alvarez-Sabin, José, Pozo-Rosich, Patricia · 2020 · Cephalalgia

Abstract

Objective: To define headache characteristics and evolution in relation to COVID-19 and its inflammatory response. Methods: This is a prospective study, comparing clinical data and inflammatory biomarkers of COVID-19 patients with and without headache, recruited at the Emergency Room. We compared baseline with 6-week follow-up to evaluate disease evolution. Results: Of 130 patients, 74.6% (97/130) had headache. In all, 24.7% (24/97) of patients had severe pain with migraine-like features. Patients with headache had more anosmia/ageusia (54.6% vs. 18.2%; p < 0.0001). Clinical duration of COVID-19 was shorter in the headache group (23.9 ± 11.6 vs. 31.2 ± 12.0 days; p = 0.028). In the headache group, IL-6 levels were lower at the ER (22.9 (57.5) vs. 57.0 (78.6) pg/mL; p = 0.036) and more stable during hospitalisation. After 6 weeks, of 74 followed-up patients with headache, 37.8% (28/74) had ongoing headache. Of these, 50% (14/28) had no previous headache history. Headache was the prodromal symptom of COVID-19 in 21.4% (6/28) of patients with persistent headache ( p = 0.010). Conclusions: Headache associated with COVID-19 is a frequent symptom, predictive of a shorter COVID-19 clinical course. Disabling headache can persist after COVID-19 resolution. Pathophysiologically, its migraine-like features may reflect an activation of the trigeminovascular system by inflammation or direct involvement of SARS-CoV-2, a hypothesis supported by concomitant anosmia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0333102420965157

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Metadata

Authors
Caronna, E., Ballvé, A., Llauradó, A., Gallardo, V. J., Ariton, D. M., Lallana, S., López Maza, S., Olivé Gadea, M., Quibus, L., Restrepo, J. L., Rodrigo-Gisbert, M., Vilaseca, A., Hernandez Gonzalez, M., Martinez Gallo, M., Alpuente, A., Torres-Ferrus, M., Pujol Borrell, R., Alvarez-Sabin, J., & Pozo-Rosich, P.
Venue
Cephalalgia
Published
2020-11
Volume
40
Issue
13
Pages
1410-1421
ISSN
  • 0333-1024 (ISSN-L)
  • 1468-2982
OpenAlex
W3095173419
Cited by
224
References
10
FWCI
15.67
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. https://app.cochat.ai/papers/10.1177/0333102420965157
The paper
Caronna, E., Ballvé, A., Llauradó, A., Gallardo, V. J., Ariton, D. M., Lallana, S., López Maza, S., Olivé Gadea, M., Quibus, L., Restrepo, J. L., Rodrigo-Gisbert, M., Vilaseca, A., Hernandez Gonzalez, M., Martinez Gallo, M., Alpuente, A., Torres-Ferrus, M., Pujol Borrell, R., Alvarez-Sabin, J., & Pozo-Rosich, P. (2020). Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. https://doi.org/10.1177/0333102420965157

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.